Clinical trial
Azithromycin in Control of Trachoma II
NCT00286026 · University of California, San Francisco, Other · Withdrawn
Key facts
| NCT number | NCT00286026 |
|---|---|
| Title | Azithromycin in Control of Trachoma II |
| Official title | Azithromycin in Control of Trachoma II |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Trachoma |
| Intervention type | Drug |
| Interventions | Azithromycin |
| Enrollment | 0 |
| Start date | Jun 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2009 |
| First posted | Feb 2, 2006 |
| Last update posted | Apr 16, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: